Your browser doesn't support javascript.
loading
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis.
Spekhorst, Lotte S; Bakker, Daphne; Drylewicz, Julia; Rispens, Theo; Loeff, Floris; Boesjes, Celeste M; Thijs, Judith; Romeijn, Geertruida L E; Loman, Laura; Schuttelaar, Marie-Louise; van Wijk, Femke; de Graaf, Marlies; de Bruin-Weller, Marjolein S.
Afiliação
  • Spekhorst LS; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Bakker D; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Drylewicz J; Division Laboratories, Pharmacy and Biomedical Genetics, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Rispens T; Department of Immunopathology, Sanquin Research, and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Loeff F; Sanquin Diagnostic Services, Sanquin, Amsterdam, The Netherlands.
  • Boesjes CM; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Thijs J; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Romeijn GLE; Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands.
  • Loman L; Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands.
  • Schuttelaar ML; Department of Dermatology, University Medical Center Groningen, Groningen, The Netherlands.
  • van Wijk F; Division Laboratories, Pharmacy and Biomedical Genetics, Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • de Graaf M; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
  • de Bruin-Weller MS; Department of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
Allergy ; 77(11): 3398-3407, 2022 11.
Article em En | MEDLINE | ID: mdl-35837880
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Adult / Humans Idioma: En Revista: Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Limite: Adult / Humans Idioma: En Revista: Allergy Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda